Robotic First Rib Resection for Thoracic Outlet Syndrome.


Journal

Surgical technology international
ISSN: 1090-3941
Titre abrégé: Surg Technol Int
Pays: United States
ID NLM: 9604509

Informations de publication

Date de publication:
28 May 2020
Historique:
pubmed: 11 12 2019
medline: 3 6 2020
entrez: 11 12 2019
Statut: ppublish

Résumé

First rib resection is a key component of the treatment of Thoracic Outlet Syndrome (TOS). We report our experience with, and technique for, robotic first rib resection. Patients diagnosed with TOS underwent robotic first rib resection of the offending portion of the first rib with disarticulation of the costo-sternal joint. Definitive diagnosis of TOS was made by Magnetic Resonance Angiography (MRA) with maneuvers. A total of 67 patients underwent robotic first rib resection. Neurogenic TOS: 39 patients underwent robotic resection for Neurologic Symptoms of the upper extremity (Neurogenic TOS). There were 14 men and 25 women, with a mean age of 34 ± 9.5 years. Paget-Schroetter Syndrome (PSS) or Venous TOS: 28 patients underwent transthoracic robotic first rib resection for PSS. There were 16 men and 12 women, with a mean age of 24 ± 8.5 years. Operative time was 87.6 ± 10.8 minutes. There were no intraoperative complications. Hospital stay ranged from 2 to 4 days with a median hospitalization of 3 days. There were no neurovascular complications. There was no mortality. In patients with Neurogenic TOS, QuickDASH Scores (mean ± SEM) decreased from 60.3 ± 2.1 preoperatively to 5 ± 2.3 in the immediate postoperative period and to 3.5 ± 1.1 at 6 months (p<0001). Immediate relief of symptoms was seen in 35/39 patients (91%). Persistent paresthesia was seen in 4/39 (9%) immediately postop, and in 2/39 (2.5%) at 6 months. Thirty-seven of 39 (97.5%) patients reported complete relief of symptoms. Among patients with PSS or Venous TOS, 9/28 (32%) required endovascular venoplasty to completely open the subclavian vein after the relief of extrinsic compression. At a median follow-up of 24 months, all patients with PSS had an open subclavian vein, for a patency rate of 100%. Robotic transthoracic first rib resection allows for minimally invasive resection of the first rib in patients with TOS, with excellent relief of symptoms and no neurovascular complications.

Identifiants

pubmed: 31821522
pii: sti36/1228

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

239-244

Auteurs

Farid Gharagozloo (F)

Center for Advanced Thoracic Surgery, Global Robotics Institute, Advent Health, University of Central Florida, Celebration, FL.

Mark Meyer (M)

Wellington Regional Medical Center, Wellington, FL.

Barbara Tempesta (B)

Center for Advanced Thoracic Surgery, Global Robotics Institute, Advent Health, University of Central Florida, Celebration, FL.

Scott Werden (S)

Center for Advanced Thoracic Surgery, Global Robotics Institute, Advent Health, University of Central Florida, Celebration, FL.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH